Ozempic is one of the best-known names in the whole weight loss medicine conversation, which is exactly why it causes so much confusion.
Many people in the UK search for “Ozempic for weight loss” when what they really want to know is whether semaglutide can help them lose weight, whether they can get it on the NHS, how much it costs privately, and whether Ozempic is the same thing as Wegovy. Those are reasonable questions, but the answers are not always obvious because the public conversation often mixes diabetes treatment, weight management treatment and off-label private prescribing together.
The key point is this: Ozempic contains semaglutide, but in the UK it is licensed for type 2 diabetes, not as the main obesity-branded semaglutide product for weight loss. For obesity treatment, the semaglutide brand people usually mean is Wegovy. NHS England said in April 2026 that semaglutide is already available on the NHS in England as a treatment option for people with obesity when offered through specialist weight management services, while Ozempic is widely prescribed by the NHS as a treatment for people with type 2 diabetes.
This guide explains what Ozempic is, whether it is used for weight loss in the UK, what it may cost privately, whether you can get it on the NHS, how it compares with Wegovy, and what to expect if semaglutide is part of your treatment plan.
If you want the wider background too, it may help to read Weight Loss Injections in the UK: Who They’re For, Risks, Costs and What to Expect and Mounjaro vs Wegovy: Which Weight Loss Injection is Better?.
What is Ozempic?
Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist. According to the official UK product information, Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
That matters because many people assume Ozempic is simply “the weight loss jab”. In UK medical terms, that is not quite right. Semaglutide exists in more than one brand and setting. Ozempic is the diabetes brand. Wegovy is the semaglutide brand specifically indicated for weight management and weight loss maintenance in adults with obesity, or overweight with at least one weight-related condition.
Can Ozempic help with weight loss?
Yes, semaglutide can lead to weight loss, which is one reason Ozempic became so widely talked about beyond diabetes care. But there is an important UK regulatory distinction: the MHRA has said that Ozempic is prescribed for patients with type 2 diabetes, while Wegovy is the semaglutide product indicated for weight management and cardiovascular risk reduction in people who are overweight or obese.
So when people say “Ozempic for weight loss”, what they often mean medically is semaglutide for weight loss. In the UK, that usually points more appropriately towards Wegovy than Ozempic, unless a clinician is prescribing Ozempic off-label in a particular situation. The MHRA warned in 2023 that Ozempic is not authorised for weight loss, although it has been used off-label for that purpose.
Is Ozempic licensed for weight loss in the UK?
No, not as Ozempic. The official UK Summary of Product Characteristics for Ozempic lists type 2 diabetes as its indication. By contrast, the Wegovy product information lists weight management, including weight loss and weight maintenance, in adults with an initial BMI of 30 or more, or 27 to under 30 with at least one weight-related comorbidity.
This distinction is one of the most important takeaways from the whole article. Ozempic and Wegovy both contain semaglutide, but they do not sit in exactly the same place clinically or regulatorily in the UK.
Can you get Ozempic on the NHS for weight loss?
Generally, not as Ozempic for obesity treatment. NHS England said in April 2026 that Ozempic is widely prescribed by the NHS as a treatment for people with type 2 diabetes, while semaglutide for obesity is available through specialist weight management services under the Wegovy pathway.
So if you are asking, “Can I get Ozempic on the NHS because I want help losing weight?” the more accurate NHS answer is usually that semaglutide for obesity is accessed through the Wegovy route, not via routine Ozempic prescribing. NHS England’s obesity medicines page also says the NHS in England prescribes weight loss medications only to patients living with obesity who meet specific criteria under NICE guidance.
If you have type 2 diabetes, Ozempic may be prescribed on the NHS as part of diabetes care where clinically appropriate. But that is a different pathway from getting semaglutide for obesity treatment.
How do people get Ozempic privately in the UK?
Private prescribing does exist, but this is where readers need to be especially careful. Some private providers discuss semaglutide generally in weight-loss treatment pathways, but UK regulators have been increasingly clear that GLP-1 medicines should only be used within their licensed use and through legitimate, regulated supply. The MHRA says these medicines should only be used if you are overweight or diabetic, and not for aesthetic or cosmetic weight loss. :contentReference[oaicite:12]{index=12}
In practical terms, if you are seeking semaglutide privately for weight loss in the UK, a properly regulated service will often steer you towards Wegovy rather than Ozempic, because Wegovy is the obesity-indicated semaglutide brand. That is one reason many mainstream UK online providers promote Wegovy and Mounjaro in their weight-management services rather than focusing on Ozempic as a weight-loss product.
How much does semaglutide cost privately in the UK?
Private cost varies by provider and dose, and prices can change quickly. Publicly listed UK online-doctor pricing shows that semaglutide weight-loss treatment under the Wegovy brand commonly starts around £99 for the lowest dose and rises through higher doses, with listed prices above £200 at later stages depending on dose and provider. For example, Superdrug Online Doctor’s published comparison page lists Wegovy from £99 at 0.25mg, rising across higher strengths.
That means the realistic question is not just “How much is the first month?” but “What will semaglutide cost over several months if I continue?” Because dose escalation usually changes the price, and weight-loss injections are rarely a one-off purchase.
If someone does receive Ozempic privately rather than Wegovy, pricing can vary even more and may not always be transparently listed in the same way, partly because Ozempic is not the main obesity-branded semaglutide route in UK consumer-facing weight-management services. That is another reason readers should look carefully at what brand is actually being prescribed and why.
What does taking semaglutide actually feel like?
Most people do not experience semaglutide as dramatic fat loss from nowhere. They experience it as appetite change. The NHS says weight-management injections such as semaglutide work by helping reduce appetite, making people feel fuller and slowing stomach emptying.
In real life, that may mean smaller portions feel enough, cravings reduce, “food noise” quietens down, and grazing becomes less tempting. For some people, that feels genuinely transformative. For others, the main early experience is side effects rather than relief.
That is why expectations matter. Semaglutide does not remove the need for dietary and habit change. It is meant to make those changes more manageable, not unnecessary.
What side effects should people know about?
The most common side effects are gastrointestinal. Nausea, vomiting, diarrhoea, constipation and stomach discomfort are all well-known issues with GLP-1 medicines. The MHRA and NHS both stress that these are real prescription medicines with real side-effect profiles and should only be used under proper clinical oversight.
Side effects often become more noticeable during dose increases, which is one reason gradual escalation matters. A provider that barely explains how to manage side effects or what to do if symptoms are severe is not offering good care.
Is Ozempic better than Wegovy?
This is a slightly misleading comparison, because they both contain semaglutide. The real difference is not the core molecule but the brand, indication and pathway. Ozempic is the diabetes brand. Wegovy is the weight-management brand.
So if you are a UK patient whose main concern is obesity treatment, the more relevant comparison is often not “Ozempic vs Wegovy” but “semaglutide vs tirzepatide” — or, more simply, Wegovy vs Mounjaro. NICE concluded that tirzepatide is more effective overall than semaglutide for managing overweight and obesity, which is why many current weight-loss comparison discussions now focus on Mounjaro vs Wegovy rather than Ozempic vs Wegovy.
If that is the question you are really trying to answer, your related article Mounjaro vs Wegovy: Which Weight Loss Injection is Better? is the natural next read.
What about safety and fake pens?
This is a real concern. The MHRA has repeatedly warned about illegal and falsified GLP-1 products in the UK market and has updated guidance for prescribers and patients. In 2026 it also issued targeted warnings in response to counterfeit and unsafe products in this category.
That means the source matters as much as the medicine. If you are going private, the safest route is a properly regulated UK provider and pharmacy, not a social-media seller, a marketplace listing or anything that feels informal. Your article Are Online Weight Loss Jabs Safe? is worth reading alongside this one for exactly that reason.
So what should UK patients actually do?
If your goal is weight loss and you are trying to understand semaglutide in the UK, the first thing is to stop assuming Ozempic is the main official route. For obesity treatment, the clinically and regulatorily clearer UK path is usually Wegovy, whether through NHS specialist services or legitimate private obesity treatment.
If your goal is diabetes treatment and your clinician thinks semaglutide is appropriate, Ozempic may be the relevant brand. But those are different conversations, even though the active ingredient overlaps.
So the smarter question is often not “How do I get Ozempic for weight loss?” but “Am I looking for semaglutide obesity treatment, and if so, what is the right UK route for that?”.
The bottom line
Ozempic contains semaglutide, and semaglutide can help with weight loss. But in the UK, Ozempic is licensed for type 2 diabetes, while Wegovy is the semaglutide brand indicated for weight management. NHS England has confirmed that semaglutide for obesity is available via specialist weight management services, while Ozempic is widely prescribed in the NHS for diabetes.
So if you are searching for “Ozempic for weight loss UK”, the most accurate answer is usually this: semaglutide may be relevant, but the proper obesity route in the UK is more often Wegovy than Ozempic. Private semaglutide costs vary, commonly starting around £99 for low-dose Wegovy and increasing as the dose rises. And whichever route you consider, it should be through a regulated medical service, not an informal seller.
If what you really want is the best current obesity-injection comparison, you may now be better served by looking at Mounjaro vs Wegovy rather than Ozempic alone.
